Inhibikase therapeutics stock price

Author: bigc

August undefined, 2024

WebbView the latest Inhibikase Therapeutics Inc. (IKT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Webb31 jan. 2024 · Each are of Stock will have the exercise price of $4.64 per share off common storage and are exercisable on and after July 1, 2024. ... 2024, subject to the satisfaction of customary closing conditions. Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), ...

Where will Inhibikase Therapeutics Stock Be In 1 Year?

Webb6 apr. 2024 · Inhibikase Therapeutics - IKT - Stock Price Today - Zacks Inhibikase Therapeutics (IKT) (Delayed Data from NSDQ) $0.72 USD 0.00 (0.63%) Updated Mar … Webb28 mars 2024 · Inhibikase Therapeutics Inc. (NASDAQ:IKT) traded at $0.76 at close of the session on Monday, 03/27/23, made an upward move of 6.01% on its previous day’s price. Looking at the stock we see that its previous close was $0.72 and the beta (5Y monthly) reads 1.03 with the day’s price range being $0.7229 – $0.8199. cv for student visa application

IKT: Inhibikase Therapeutics Inc Stock Price Quote - Bloomberg

WebbIKT: Inhibikase Therapeutics Inc - Stock Price, Quote and News - CNBC Inhibikase Therapeutics Inc IKT:NASDAQ EXPORT WATCHLIST + LIVE SQUAWK BOX RT … Webb30 jan. 2024 · Inhibikase Therapeutics, Inc. is a pharmaceutical company focused on the development of protein kinase inhibitors for treatment of neurological infections and … WebbWhat this means: InvestorsObserver gives Inhibikase Therapeutics Inc. (IKT) an overall rank of 30, which is below average. Inhibikase Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 30 means that 70% of stocks appear more favorable to our system. cv for college application

Transcript : Inhibikase Therapeutics, Inc., Q4 2024 Earnings Call, …

Inhibikase Therapeutics Inc (IKT) Stock Price & News - Google

WebbWebull offers kinds of Inhibikase Therapeutics Inc stock information, including NASDAQ:IKT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IKT stock news, and many more online research tools to help you make informed decisions. WebbSelected key stats of Inhibikase Therapeutics, Inc. (IKT) including 10 year stock price and latest news. Key stats provide selected financials for rapid company overview including revenues, marketcap, ... Created with Highcharts 8.2.2 price 0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 Zoom 1m 3m 6m YTD 1y 3y 5y All 0.66. Target Price Range. High ... radionikkeyWebbInhibikase Therapeutics Inc is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders. Its multi-therapeutic pipeline focuses on ... cv formato europeo unifi

"WebbInhibikase Therapeutics PE ratio as of February 09, 2024 is 0.00. Please refer to the Stock Price Adjustment Guide for more information on our historical prices. Compare IKT With Other Stocks From: To: Zoom: 0.5 1.0 1.5 Stock Price -0.85 -0.80 -0.75 -0.70 TTM Net EPS Dec Mar Jun Sep Feb 0 5 PE Ratio Dec Mar Jun Sep Feb " - Inhibikase therapeutics stock price

Inhibikase therapeutics stock price

Inhibikase Therapeutics, Inc. Common Stock (IKT) Stock …

Webb3 apr. 2024 · Nasdaq Inhibikase Therapeutics, Inc. News Summary IKT US45719W1062 INHIBIKASE THERAPEUTICS, INC. (IKT) Add to my list Report Summary Quotes Charts News Calendar Company Financials Funds Summary All News Analyst Reco. Official Publications Sector news Transcript : Inhibikase Therapeutics, Inc., Q4 2024 … Webb29 mars 2024 · The stock’s fifty day moving average price is $0.72 and its 200-day moving average price is $0.70. Get Inhibikase Therapeutics alerts: Institutional Inflows and Outflows

Did you know?

Webb12 apr. 2024 · Inhibikase Therapeutics, Inc. (IKT) Stock Price, Quote & News - Stock Analysis Inhibikase Therapeutics, Inc. ( IKT) NASDAQ: IKT · USD Add to Watchlist … WebbINHIBIKASE THERAPEUTICS INC COM USD0.001. Symbol: IKT. Buy 0.53. Sell 0.5094. ... 0.5351: Open: 0.523: Volume: 80,761: Div Yield(%) 0: Year High: 1.43: Year Low: 0.4401: Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working …

Webb10 apr. 2024 · IKT - Inhibikase Therapeutics Inc Ordinary Shares Stock Price Quote - NASDAQ Morningstar Inhibikase Therapeutics Inc Ordinary Shares IKT Stock … Webb10 apr. 2024 · Inhibikase Therapeutics Inc. Watch list Create IKT Alert After Hours Last Updated: Apr 6, 2024 7:37 p.m. EDT Delayed quote $ 0.5678 0.01 1.81% After Hours …

WebbFind the latest Inhibikase Therapeutics, Inc. (IQT.F) stock quote, history, news and other vital information to help you with your stock trading and investing. WebbIKT - Stock Price Chart IKT [NASD] Inhibikase Therapeutics, Inc. Healthcare Biotechnology USA statements Inhibikase Therapeutics, Inc., a clinical-stage …

Webb15 juni 2024 · In addition, Inhibikase has granted the underwriters a 45-day option to purchase up to 2.25 million additional shares of common stock at the public offering …

WebbFind the latest Inhibikase Therapeutics, Inc. (IQT.F) stock quote, history, news and other vital information to help you with your stock trading and investing. cv ficha tecnicaWebb14 apr. 2024 · Regulus Therapeutics Inc. (NASDAQ:RGLS) shares, rose in value on Thursday, 04/13/23, with the stock price up by 35.54% to the previous day’s close as … radiookapi.net onlineWebbInhibikase Therapeutics Inc (IKT) Stock Price & News - Google Finance Home IKT • NASDAQ Inhibikase Therapeutics Inc Follow Share $0.53 Apr 10, 2:36:02 PM GMT-4 … cv franqo indonesiaWebbInhibikase Therapeutics Prices Follow-On Public Offering of Common Stock Monday, 17 May 2024 yahoo. Inhibikase Therapeutics Reports First Quarter 2024 Financial … cv frigoriste modèleWebbFör 1 dag sedan · What happened. Shares of CRISPR Therapeutics ( CRSP 16.66%) were up 15% Thursday morning, a day after a drug-pricing group said the company's … cv for police applicationWebb11 apr. 2024 · Inhibikase Therapeutics, Inc. (NYSE:IKT) announced its quarterly earnings results on Monday, November, 15th. The company reported ($0.18) earnings per share … radionauten allee der kosmonautenWebb28 mars 2024 · INHIBIKASE THERAPEUTICS, INC. : IKT Stock Price US45719W1062 MarketScreener Homepage Equities United States Nasdaq Inhibikase Therapeutics, … radioonkologie kantonsspital luzern